Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Similarly, symptoms suggestive of gallbladder disease warrant investigation with liver function tests and abdominal ultrasonography
The metabolic syndrome constellation (E88.81) abdominal obesity, hypertriglyceridemia, low HDL, hypertension, and elevated fasting glucose frequently co-occurs with obesity and compounds cardiovascular risk
After the initial 6 months, continued monthly visits are covered only if the patient achieved a 3 kg (6.6 lb) weight loss in the first 6 months
If you have patients who would benefit from specialized obesity medicine support, you are welcome to refer them.
In UK practice, code the clinical manifestation first (e.g., R11.0 for nausea), followed by Y42.3 (Insulin and oral hypoglycaemic drugs causing adverse effects in therapeutic use) as the secondary external cause code
Use these codes when the encounter involves medication monitoring or education: Z51.81 Drug therapy monitoring Used for follow-ups, dose adjustments, and monitoring treatment response
US$ 21.49
US$ 21.00
US$ 25.22
US$ 25.55
US$ 23.52
US$ 20.10
US$ 25.13
